Diabetic neuropathies: clinical manifestations and current treatment options
- PMID: 16932298
- DOI: 10.1038/ncpendmet0142
Diabetic neuropathies: clinical manifestations and current treatment options
Abstract
Diabetic neuropathies are a heterogeneous group of disorders that include a wide range of abnormalities. They can be focal or diffuse, proximal or distal, affecting both peripheral and autonomic nervous systems, causing morbidity with significant impact on the quality of life of the person with diabetes, and can result in early death. Distal symmetric polyneuropathy, the most common form of diabetic neuropathy, usually involves small and large nerve fibers. Small-nerve-fiber neuropathy often presents with pain but without objective signs or electrophysiologic evidence of nerve damage, and is recognized as a component of the impaired glucose tolerance and metabolic syndromes. The greatest risk resulting from small-fiber neuropathy is foot ulceration and subsequent gangrene and amputation. Large-nerve-fiber neuropathies produce numbness, ataxia and uncoordination, impairing activities of daily living and causing falls and fractures. A careful history and detailed physical examination are essential for the diagnosis. Symptomatic therapy has become available and newer and better treatment modalities, based on etiologic factors, are being explored with potential for significant impact on morbidity and mortality. Preventive strategies and patient education still remain key factors in reducing complication rates and mortality.
Similar articles
-
Clinical manifestations and current treatment options for diabetic neuropathies.Endocr Pract. 2007 Sep;13(5):550-66. doi: 10.4158/EP.13.5.550. Endocr Pract. 2007. PMID: 17872358 Review.
-
Medical evaluation and treatment of diabetic peripheral neuropathy.Clin Podiatr Med Surg. 2003 Oct;20(4):671-88. doi: 10.1016/S0891-8422(03)00068-5. Clin Podiatr Med Surg. 2003. PMID: 14636032 Review.
-
Evaluation and prevention of diabetic neuropathy.Am Fam Physician. 2005 Jun 1;71(11):2123-8. Am Fam Physician. 2005. PMID: 15952441 Review.
-
Diabetic neuropathy--a review.Nat Clin Pract Neurol. 2007 Jun;3(6):331-40. doi: 10.1038/ncpneuro0504. Nat Clin Pract Neurol. 2007. PMID: 17549059 Review.
-
[Diabetic neuropathy--a clinical review].Tidsskr Nor Laegeforen. 2005 Jun 16;125(12):1646-9. Tidsskr Nor Laegeforen. 2005. PMID: 15976830 Review. Norwegian.
Cited by
-
Glu-Ensemble: An ensemble deep learning framework for blood glucose forecasting in type 2 diabetes patients.Heliyon. 2024 Apr 4;10(8):e29030. doi: 10.1016/j.heliyon.2024.e29030. eCollection 2024 Apr 30. Heliyon. 2024. PMID: 38638954 Free PMC article.
-
Individuals Diagnosed With Type 2 Diabetes Mellitus and the Status of Vitamin B12 Deficiency: A Review.Cureus. 2024 Feb 27;16(2):e55103. doi: 10.7759/cureus.55103. eCollection 2024 Feb. Cureus. 2024. PMID: 38558585 Free PMC article. Review.
-
Correlation study of renal function indices with diabetic peripheral neuropathy and diabetic retinopathy in T2DM patients with normal renal function.Front Public Health. 2023 Dec 15;11:1302615. doi: 10.3389/fpubh.2023.1302615. eCollection 2023. Front Public Health. 2023. PMID: 38174078 Free PMC article.
-
FABP3, FABP4, and heart rate variability among patients with chronic schizophrenia.Front Endocrinol (Lausanne). 2023 May 15;14:1165621. doi: 10.3389/fendo.2023.1165621. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37255976 Free PMC article.
-
Ameliorative Effects of Isoeugenol and Eugenol against Impaired Nerve Function and Inflammatory and Oxidative Mediators in Diabetic Neuropathic Rats.Biomedicines. 2023 Apr 18;11(4):1203. doi: 10.3390/biomedicines11041203. Biomedicines. 2023. PMID: 37189822 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical